wow, I wake up to this. Apparently you're a pro, I'm sorry for offending your great intelligence. The point I was making is that the other issues people fret over, such as marketing relationships, cash, etc... aren't that important. To understand this stock is to try to figure out the path of the continuing improvement in PG. I happen to believe it is inevitable that the sensitivity of PG approaches that of a colonscopy, although won't quite reach it. MHO, is that the probability of PG continuing to improve significantly is high enough to take a 1-3% roll on EXAS.